142 related articles for article (PubMed ID: 34848510)
1. Association between multimorbidity and socioeconomic deprivation on short-term mortality among patients with diffuse large B-cell or follicular lymphoma in England: a nationwide cohort study.
Smith MJ; Njagi EN; Belot A; Leyrat C; Bonaventure A; Benitez Majano S; Rachet B; Luque Fernandez MA
BMJ Open; 2021 Nov; 11(11):e049087. PubMed ID: 34848510
[TBL] [Abstract][Full Text] [Related]
2. Excess Mortality by Multimorbidity, Socioeconomic, and Healthcare Factors, amongst Patients Diagnosed with Diffuse Large B-Cell or Follicular Lymphoma in England.
Smith MJ; Belot A; Quartagno M; Luque Fernandez MA; Bonaventure A; Gachau S; Benitez Majano S; Rachet B; Njagi EN
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830964
[TBL] [Abstract][Full Text] [Related]
3. Mediating Effects of Diagnostic Route on the Comorbidity Gap in Survival of Patients with Diffuse Large B-Cell or Follicular Lymphoma in England.
Smith MJ; Rachet B; Luque-Fernandez MA
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291866
[No Abstract] [Full Text] [Related]
4. Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England.
Smith MJ; Fernandez MAL; Belot A; Quartagno M; Bonaventure A; Majano SB; Rachet B; Njagi EN
Br J Cancer; 2021 Oct; 125(9):1299-1307. PubMed ID: 34389805
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020-2025.
Kanas G; Ge W; Quek RGW; Keeven K; Nersesyan K; Jon E Arnason
Leuk Lymphoma; 2022 Jan; 63(1):54-63. PubMed ID: 34510995
[TBL] [Abstract][Full Text] [Related]
7. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
Ren J; Asche CV; Shou Y; Galaznik A
J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
[TBL] [Abstract][Full Text] [Related]
9. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
[TBL] [Abstract][Full Text] [Related]
10. Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
Ritter AJ; Goldstein JS; Ayers AA; Flowers CR
Leuk Lymphoma; 2019 Jul; 60(7):1656-1667. PubMed ID: 30632824
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCale.
Dürig J; Uhlig J; Gerhardt A; Ritter M; Hapke G; Heßling J; Staib P; Wolff F; Krumm K; von Weikersthal LF
Cancer Med; 2023 Feb; 12(3):2739-2751. PubMed ID: 36017743
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort study.
Vaughn JL; Epperla N
Biomark Res; 2023 Sep; 11(1):84. PubMed ID: 37759262
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].
Lin ZJ; Zha J; Yi SH; Li ZF; Ping LY; He XH; Yu HF; Zheng Z; Xu W; Chen FL; Xie Y; Chen BY; Zhang HL; Wang L; Ding KY; Li WY; Yang HY; Zhao WL; Qiu LG; Li ZM; Song YQ; Xu B
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):456-462. PubMed ID: 35968587
[No Abstract] [Full Text] [Related]
15. Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era.
Nowakowski GS; Maurer MJ; Habermann TM; Ansell SM; Macon WR; Ristow KM; Allmer C; Slager SL; Witzig TE; Cerhan JR
J Clin Oncol; 2010 Jan; 28(3):412-7. PubMed ID: 20008638
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.
Charbonneau B; Maurer MJ; Ansell SM; Slager SL; Fredericksen ZS; Ziesmer SC; Macon WR; Habermann TM; Witzig TE; Link BK; Cerhan JR; Novak AJ
Cytokine; 2012 Dec; 60(3):882-9. PubMed ID: 23010502
[TBL] [Abstract][Full Text] [Related]
17. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
[TBL] [Abstract][Full Text] [Related]
18. Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with
Uryu H; Mishima Y; Tsuyama N; Yokoyama M; Nishimura N; Fukuta T; Shirouchi Y; Okabe T; Inoue N; Takeuchi K; Terui Y
Leuk Lymphoma; 2021 Sep; 62(9):2141-2150. PubMed ID: 33749498
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.
Chen Y; Luo L; Chen L; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Yang T; Hu J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2311-2318. PubMed ID: 36219261
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
Almasri NM; Al-Alami J; Faza M
Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
